166
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Comparing Mycobacterium tuberculosis RNA Accuracy in Various Respiratory Specimens for the Rapid Diagnosis of Pulmonary Tuberculosis

, , , ORCID Icon &
Pages 4195-4202 | Published online: 03 Aug 2022

References

  • World Health Organization. Global Tuberculosis Report 2021. World Health Organization; 2021.
  • Ahmad M, Ibrahim WH, Sarafandi SA, et al. Diagnostic value of bronchoalveolar lavage in the subset of patients with negative sputum/smear and mycobacterial culture and a suspicion of pulmonary tuberculosis. Int J Infect Dis. 2019;82:96–101.
  • Thangavelu K, Krishnakumariamma K, Pallam G, et al. Prevalence and speciation of non-tuberculous mycobacteria among pulmonary and extrapulmonary tuberculosis suspects in South India. J Infect Public Health. 2021;14(3):320–323.
  • Malede A, Taye B, Legesse M, Debie A, Shibabaw A. Pulmonary tuberculosis preventive practices among Anibessa Bus users at Addis Ababa, Ethiopia: a cross-sectional study. BMC Res Notes. 2019;12(1):104.
  • Kang W, Yu J, Du J, et al. The epidemiology of extrapulmonary tuberculosis in China: a large-scale multi-center observational study. PLoS One. 2020;15(8):e0237753.
  • Biadglegne F, Schmidt JR, Engel KM, et al. Mycobacterium tuberculosis Affects Protein and Lipid Content of Circulating Exosomes in Infected Patients Depending on Tuberculosis Disease State. Biomedicines. 2022;10(4):87.
  • Boardman NJ, Moore T, Freiman J, et al. Pulmonary Tuberculosis Disease Among Immigrant Detainees: rapid Disease Detection, High Prevalence of Asymptomatic Disease, and Implications for Tuberculosis Prevention. Clin Infect Dis. 2021;73(1):115–120.
  • Luetkemeyer AF, Firnhaber C, Kendall MA, et al. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings. Clin Infect Dis. 2016;62(9):1081–1088.
  • Fachri M, Hatta M, Abadi S, et al. Comparison of acid fast bacilli (AFB) smear for Mycobacterium tuberculosis on adult pulmonary tuberculosis (TB) patients with type 2 diabetes mellitus (DM) and without type 2 DM. Respir Med Case Rep. 2018;23:158–162.
  • Yu G, Shen Y, Ye B, Chen D, Xu K. Comparison of CapitalBio™ Mycobacterium nucleic acid detection test and Xpert MTB/RIF assay for rapid diagnosis of extrapulmonary tuberculosis. J Microbiol Methods. 2020;168:105780.
  • Sun L, Yao L, Fu G, Lin L, Zhu E, Huang J. A comparison of the accuracy of the CapitalBio Mycobacterium real-time polymerase chain reaction and the Xpert MTB/RIF assay for the diagnosis of tuberculous meningitis. Int J Infect Dis. 2021;104:92–96.
  • Yu G, Wang X, Zhu P, Shen Y, Zhao W, Zhou L. Comparison of the efficacy of metagenomic next-generation sequencing and Xpert MTB/RIF in the diagnosis of tuberculous meningitis. J Microbiol Methods. 2021;180:106124.
  • Shen Y, Fang L, Xu X, Ye B, Yu G. CapitalBio Mycobacterium real-time polymerase chain reaction detection test: rapid diagnosis of Mycobacterium tuberculosis and nontuberculous mycobacterial infection. Int J Infect Dis. 2020;98:1–5.
  • Yu G, Shen Y, Ye B, Shi Y. Diagnostic accuracy of Mycobacterium tuberculosis cell-free DNA for tuberculosis: a systematic review and meta-analysis. PLoS One. 2021;16(6):e0253658.
  • Yu G, Wang L, Shen Y, et al. Comparison of the Diagnostic Accuracy of Xpert MTB/RIF and CapitalBio Mycobacterium RT-PCR Detection Assay for Tuberculous Pericarditis. Infect Drug Resist. 2022;15:2127–2135.
  • Chen Y, Zhang L, Hong L, et al. Rapid diagnosis of pulmonary tuberculosis and detection of drug resistance by combined simultaneous amplification testing and reverse dot blot. J Clin Pathol. 2018;71(6):498–503.
  • Li QH, Zhang Y, Zhao MM, et al. Simultaneous amplification and testing method for Mycobacterium tuberculosis rRNA to differentiate sputum-negative tuberculosis from sarcoidosis. Am J Physiol Lung Cell Mol Physiol. 2019;316(3):L519–l524.
  • Li T, Shi T, Sun Y, et al. Application of real-time simultaneous amplification and testing method to accurately and rapidly detect extra-pulmonary tuberculosis. BMC Infect Dis. 2020;20(1):303.
  • Qiu C, Pan N, Zhou Y, et al. Application Value of SAT-TB Combined with Acid-Fast Staining in the Diagnosis and Treatment of Pulmonary Tuberculosis. Biomed Res Int. 2020;2020:3620425.
  • Yan L, Zhang Q, Xiao H. Clinical diagnostic value of simultaneous amplification and testing for the diagnosis of sputum-scarce pulmonary tuberculosis. BMC Infect Dis. 2017;17(1):545.
  • National Health Commission of the People’s Republic of China. Health Industry Standard of the People’s Republic of China - Diagnosis for pulmonary tuberculosis (WS 288-2017). Chin J Infection Control. 2018;17:642–652.
  • Yu G, Zhong F, Zhao W, Ye B, Xu K, Chen G. Head-to-head comparison of the diagnostic value of five tests for constrictive tuberculous pericarditis: five tests for constrictive TBP. Int J Infect Dis. 2022;120:25–32.
  • Shen Y, Fang L, Ye B, Xu X, Yu G, Zhou L. The Role of Core Needle Biopsy Pathology Combined with Molecular Tests in the Diagnosis of Lymph Node Tuberculosis. Infect Drug Resist. 2022;15:335–345.
  • Yan L, Xiao H, Zhang Q. Using simultaneous amplification and testing method for evaluating the treatment outcome of pulmonary tuberculosis. BMC Infect Dis. 2018;18(1):512.
  • Bardou P, Mariette J, Escudié F, Djemiel C, Klopp C. jvenn: an interactive Venn diagram viewer. BMC Bioinform. 2014;15(1):293.
  • Sebastian NM, Haveri SP, Nath AS. Delay in diagnosis of tuberculosis and related factors from a district in Kerala, India. Indian J Tuberc. 2021;68(1):59–64.
  • Zheng H, Zhong F, Yu G, Shen Y. Comparison of the diagnostic efficacy of the CapitalBio Mycobacterium real-time polymerase chain reaction detection test and Xpert MTB/RIF in smear-negative pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis. 2021;40(5):969–977.
  • Liu X, Chen Y, Ouyang H, et al. Tuberculosis Diagnosis by Metagenomic Next-generation Sequencing on Bronchoalveolar Lavage Fluid: a cross-sectional analysis. Int J Infect Dis. 2021;104:50–57.
  • Mondoni M, Repossi A, Carlucci P, Centanni S, Sotgiu G. Bronchoscopic techniques in the management of patients with tuberculosis. Int J Infect Dis. 2017;64:27–37.
  • Gowda NC, Ray A, Soneja M, Khanna A, Sinha S. Evaluation of Xpert(®)Mycobacterium tuberculosis/rifampin in sputum-smear negative and sputum-scarce patients with pulmonary tuberculosis using bronchoalveolar lavage fluid. Lung India. 2018;35(4):295–300.
  • Liu HC, Gao YL, Li DF, Zhao XY, Pan YQ, Zhu CT. Value of Xpert MTB/RIF Using Bronchoalveolar Lavage Fluid for the Diagnosis of Pulmonary Tuberculosis: a Systematic Review and Meta-analysis. J Clin Microbiol. 2021;59(4):1.
  • Nsubuga R, Adrawa N, Okoboi S, Komuhangi A, Izudi J. Complete sputum smear monitoring among adults with pulmonary tuberculosis in central Uganda: evidence from a retrospective cohort study. BMC Infect Dis. 2022;22(1):191.
  • Shaikh A, Sriraman K, Vaswani S, Oswal V, Mistry N. Detection of Mycobacterium tuberculosis RNA in bioaerosols from pulmonary tuberculosis patients. Int J Infect Dis. 2019;86:5–11.